![Bigfoot Biomedical announces $45M Series C tranche, expands partnership with Abbott | MobiHealthNews Bigfoot Biomedical announces $45M Series C tranche, expands partnership with Abbott | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/bigfoot%20thumb_0.png)
Bigfoot Biomedical announces $45M Series C tranche, expands partnership with Abbott | MobiHealthNews
NEWS: FDA cleared the Bigfoot Unity System, which integrates with our FreeStyle Libre 2 sensor, making it the only smart insulin pen system that uses... | By Abbott | Facebook
![Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Management System, Featuring First-of-its-Kind Smart Pen Caps for Insulin Pens used to Treat Type 1 and Type 2 Diabetes | Business Wire Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Management System, Featuring First-of-its-Kind Smart Pen Caps for Insulin Pens used to Treat Type 1 and Type 2 Diabetes | Business Wire](https://mms.businesswire.com/media/20210510005229/en/877059/5/high1280.jpg)